Abate As Industries Ltd
Incorporated in 1991, Abate As Industries
Ltd primarily operates in the eye healthcare segment through its super specialty hospitals
and optical outlets[1]
- Market Cap ₹ 120 Cr.
- Current Price ₹ 7.60
- High / Low ₹ 20.1 / 6.56
- Stock P/E 9.74
- Book Value ₹ 11.0
- Dividend Yield 0.00 %
- ROCE 6.63 %
- ROE 5.10 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.69 times its book value
- Debtor days have improved from 245 to 59.2 days.
- Company's working capital requirements have reduced from 357 days to 75.1 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 32.4%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|
| 14 | 159 | 142 | |
| 13 | 146 | 127 | |
| Operating Profit | 1 | 13 | 14 |
| OPM % | 5% | 8% | 10% |
| 1 | 2 | 2 | |
| Interest | 0 | 1 | 1 |
| Depreciation | 1 | 2 | 2 |
| Profit before tax | 1 | 13 | 13 |
| Tax % | -2% | 6% | |
| 1 | 12 | 12 | |
| EPS in Rs | 0.05 | 0.55 | 0.78 |
| Dividend Payout % | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 157% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 263% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 10% |
| 3 Years: | -11% |
| 1 Year: | -54% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 79 | 158 |
| Reserves | 85 | 16 |
| 11 | 10 | |
| 31 | 40 | |
| Total Liabilities | 206 | 223 |
| 149 | 150 | |
| CWIP | 0 | 0 |
| Investments | 14 | 14 |
| 43 | 59 | |
| Total Assets | 206 | 223 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| -1 | 6 | |
| -162 | -2 | |
| 165 | -2 | |
| Net Cash Flow | 2 | 2 |
| Free Cash Flow | -1 | 3 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -91% | 56% |
Ratios
Consolidated / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 430 | 59 |
| Inventory Days | 413 | 49 |
| Days Payable | 209 | 36 |
| Cash Conversion Cycle | 635 | 72 |
| Working Capital Days | 640 | 75 |
| ROCE % | 7% |
Insights
In beta| Mar 2025 | Mar 2026 | |
|---|---|---|
| Healthcare Procedures Performed count |
|
|
| Operational Eye Hospitals count |
||
| Planned Eye Hospitals (Target Network) count |
||
| Students Trained (Cumulative) count |
||
| Educational Institutions count |
||
| Healthcare Revenue Mix % of consolidated revenue |
||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
- Entered 24-month franchise development agreement with Franchise India Brands for ABATE Eye Hospital expansion; value Rs 30 lakh.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Regulation 74(5) confirmation certificate issued for quarter ended 30 September 2026; no shares dematerialised.
- Closure of Trading Window
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Shareholder Meeting / Postal Ballot-Outcome of AGM
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Concalls
-
Jun 2026Transcript
Business Overview:[1]
AAIL is a multi-sector enterprise with a diverse portfolio in healthcare, education, retail, technology, real estate, and consultancy
services.